High glycolytic flux to meet the elevated tumor demands for energetic and biosynthetic precursors needed for survival and proliferation requires the proper function of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) [16]. The gene discussed is PFKFB3; the disease is neoplasm.